Affordable Access

Immunotherapy of metastatic disease.

Authors
  • Talmadge, J E
  • Black, P L
Type
Published Article
Journal
Seminars in thrombosis and hemostasis
Publication Date
Jan 01, 1988
Volume
14
Issue
1
Pages
79–87
Identifiers
PMID: 3127885
Source
Medline
License
Unknown

Abstract

It appears that the cytokines have significant therapeutic potential as an adjunct to established therapeutic regimens. It appears that, as single agents, they will have minimal therapeutic activity. However, in minimal residual disease settings or after debulking regimens by surgery, chemotherapy, or radiotherapy, significantly increased therapeutic activity can be expected by the addition of cytokines to treatment protocols.

Report this publication

Statistics

Seen <100 times